159 related articles for article (PubMed ID: 11768727)
21. Long-term calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity.
Lindqvist M; Kahan T; Melcher A; Ekholm M; Hjemdahl P
J Hypertens; 2007 Jan; 25(1):169-75. PubMed ID: 17143189
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory effect of cilnidipine on pressor response to acute cold stress in spontaneously hypertensive rats.
Hosono M; Hiruma T; Watanabe K; Hayashi Y; Ohnishi H; Takata Y; Kato H
Jpn J Pharmacol; 1995 Oct; 69(2):119-25. PubMed ID: 8569048
[TBL] [Abstract][Full Text] [Related]
23. Antiproteinuric effect of cilnidipine in hypertensive Japanese treated with renin-angiotensin-system inhibitors - a multicenter, open, randomized trial using 24-hour urine collection.
Miwa Y; Tsuchihashi T; Ohta Y; Tominaga M; Kawano Y; Sasaguri T; Ueno M; Matsuoka H
Clin Exp Hypertens; 2010; 32(6):400-5. PubMed ID: 20828221
[TBL] [Abstract][Full Text] [Related]
24. The effect of an L/N-type calcium channel blocker on intradialytic blood pressure in intradialytic hypertensive patients.
Ito T; Fujimoto N; Ishikawa E; Dohi K; Fujimoto M; Murata T; Kiyohara M; Takeuchi H; Koyabu S; Nishimura H; Takeuchi T; Ito M
Clin Exp Hypertens; 2019; 41(1):92-99. PubMed ID: 29584458
[TBL] [Abstract][Full Text] [Related]
25. Contrasting effects of verapamil and amlodipine on cardiovascular stress responses in hypertension.
Lefrandt JD; Heitmann J; Sevre K; Castellano M; Hausberg M; Fallon M; Urbigkeit A; Rostrup M; Agabiti-Rosei E; Rahn KH; Murphy M; Zannad F; de Kam PJ; Smit AJ
Br J Clin Pharmacol; 2001 Dec; 52(6):687-92. PubMed ID: 11736880
[TBL] [Abstract][Full Text] [Related]
26. Effects of cilnidipine on sympathetic nerve activity and cardiorenal function in hypertensive patients with type 2 diabetes mellitus: association with BNP and aldosterone levels.
Tanaka M; Sekioka R; Nishimura T; Ichihara A; Itoh H
Diabetes Res Clin Pract; 2014 Dec; 106(3):504-10. PubMed ID: 25458339
[TBL] [Abstract][Full Text] [Related]
27. Long-term blockade of L/N-type Ca(2+) channels by cilnidipine ameliorates repolarization abnormality of the canine hypertrophied heart.
Takahara A; Nakamura Y; Wagatsuma H; Aritomi S; Nakayama A; Satoh Y; Akie Y; Sugiyama A
Br J Pharmacol; 2009 Nov; 158(5):1366-74. PubMed ID: 19785655
[TBL] [Abstract][Full Text] [Related]
28. Cilnidipine inhibits the sympathetic nerve activity and improves baroreflex sensitivity in patients with hypertension.
Kishi T; Hirooka Y; Konno S; Sunagawa K
Clin Exp Hypertens; 2009 May; 31(3):241-9. PubMed ID: 19387900
[TBL] [Abstract][Full Text] [Related]
29. Effects of cilnidipine on serum uric acid level and urinary nitrogen monoxide excretion in patients with hypertension.
Hamada T; Yamada K; Mizuta E; Watanabe A; Osaki T; Ishida K; Hasegawa A; Sakata S; Mishima M; Ogino K; Nosaka Y; Miyazaki S; Ohtahara A; Ninomiya H; Kato M; Yoshida A; Taniguchi S; Yamamoto K; Hisatome I
Clin Exp Hypertens; 2012; 34(7):470-3. PubMed ID: 22681507
[TBL] [Abstract][Full Text] [Related]
30. On the top of ARB N/L type Ca channel blocker leads to less elevation of aldosterone.
Konoshita T; Kaeriyama S; Urabe M; Nakaya T; Yamada M; Ichikawa M; Yamamoto K; Sato S; Imagawa M; Fujii M; Makino Y; Zenimaru Y; Wakahara S; Suzuki J; Ishizuka T; Nakamura H;
Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27515419
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of changes in sympathetic nerve activity and heart rate in essential hypertensive patients induced by amlodipine and nifedipine.
Hamada T; Watanabe M; Kaneda T; Ohtahara A; Kinugawa T; Hisatome I; Fujimoto Y; Yoshida A; Shigemasa C
J Hypertens; 1998 Jan; 16(1):111-8. PubMed ID: 9533424
[TBL] [Abstract][Full Text] [Related]
32. The effects of the L/N-type calcium channel blocker (cilnidipine) on sympathetic hyperactive morning hypertension: results from ACHIEVE-ONE.
Kario K; Ando S; Kido H; Nariyama J; Takiuchi S; Yagi T; Shimizu T; Eguchi K; Ohno M; Kinoshita O; Yamada T
J Clin Hypertens (Greenwich); 2013 Feb; 15(2):133-42. PubMed ID: 23339732
[TBL] [Abstract][Full Text] [Related]
33. Effects of the L/N-Type Ca
Harada E; Sugino K; Aimoto M; Takahara A
Biol Pharm Bull; 2021 May; 44(5):707-713. PubMed ID: 33642455
[TBL] [Abstract][Full Text] [Related]
34. A new-generation N/L-type calcium channel blocker leads to less activation of the renin-angiotensin system compared with conventional L type calcium channel blocker.
Konoshita T; Makino Y; Kimura T; Fujii M; Wakahara S; Arakawa K; Inoki I; Nakamura H; Miyamori I;
J Hypertens; 2010 Oct; 28(10):2156-60. PubMed ID: 20625317
[TBL] [Abstract][Full Text] [Related]
35. Cilnidipine: Next Generation Calcium Channel Blocker.
Shete MM
J Assoc Physicians India; 2016 Apr; 64(4):95-99. PubMed ID: 27734656
[TBL] [Abstract][Full Text] [Related]
36. Effects of the N/L-type calcium channel blocker cilnidipine on nephropathy and uric acid metabolism in hypertensive patients with chronic kidney disease (J-CIRCLE study).
Uchida S; Takahashi M; Sugawara M; Saito T; Nakai K; Fujita M; Mochizuki K; Shin I; Morita T; Hikita T; Itakura H; Takahashi Y; Mizuno S; Ohno Y; Ito K; Ito T; Soma M
J Clin Hypertens (Greenwich); 2014 Oct; 16(10):746-53. PubMed ID: 25264215
[TBL] [Abstract][Full Text] [Related]
37. Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases.
Kojima S; Shida M; Yokoyama H
Hypertens Res; 2004 Jun; 27(6):379-85. PubMed ID: 15253102
[TBL] [Abstract][Full Text] [Related]
38. Effects of selective angiotensin II receptor blockade on sympathetic nerve activity in primary hypertensive subjects.
Struck J; Muck P; Trübger D; Handrock R; Weidinger G; Dendorfer A; Dodt C
J Hypertens; 2002 Jun; 20(6):1143-9. PubMed ID: 12023684
[TBL] [Abstract][Full Text] [Related]
39. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
[TBL] [Abstract][Full Text] [Related]
40. Involvement of N-type Ca(2+) channels in the fibrotic process of the kidney in rats.
Mishima K; Maeshima A; Miya M; Sakurai N; Ikeuchi H; Hiromura K; Nojima Y
Am J Physiol Renal Physiol; 2013 Mar; 304(6):F665-73. PubMed ID: 23324177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
